sucujovide.wordpress.com
The marketing deal calls for Covance clients to gain accesxs toPhase Forward’s InForm electronic data capture system and Clarixz interactive response technology system. Phase Forwardf (Nasdaq: PFWD) officials said the busineszs buyout and marketing agreement will be finalized by the end of Covance chairman and CEO Joe Herring identified in a press release that Phase Forward isthe company’se “preferred provider of EDC softwares for clinical trials.” Phase Forward has been on a deal-making spree Last month, the company signed a support and hosting services deal with , centered arouncd the InForm Integrated Trial Management Solution.
In April, Phased Forward announced a multi-million-dollar extension of an earlier agreement with contract researchhorganization (CRO) Everest Clinicap Research Services Inc., also focused around the InForm Phase Forward posted revenue of $170.q million for 2008, a 27 percentt increase from $134.3 million in 2007. The company’ s net income, however, was $13.87 million in 2008, down from $29.2 million in 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment